Int J Psychiatry Clin Pract. 2001;5(1):3-10. doi: 10.1080/136515001300225132.
Depression is a common illness, frequently comorbid with other psychiatric disorders or medical illness. Comorbidity is associated with a poorer outcome for the patient, more severe symptoms and risk of suicide. The selective serotonin re-uptake inhibitor paroxetine has proven efficacy in the treatment of depression and anxiety disorders, including panic disorder, obsessive compulsive disorder and social anxiety disorder. The paper examines the role of paroxetine monotherapy in the treatment of depressed patients with comorbid anxiety, and reviews the use of paroxetine in the treatment of depression in patients suffering concurrent medical illnesses. ( Int J Psych Clin Pract 2001; 5:3-10).
抑郁症是一种常见的疾病,常与其他精神疾病或躯体疾病共病。共病与患者的预后较差、症状更严重和自杀风险增加有关。选择性 5-羟色胺再摄取抑制剂帕罗西汀已被证明在治疗抑郁症和焦虑症方面有效,包括惊恐障碍、强迫症和社交焦虑症。本文探讨了帕罗西汀单药治疗伴发焦虑的抑郁患者的作用,并综述了帕罗西汀在治疗同时患有躯体疾病的抑郁患者中的应用。(Int J Psych Clin Pract 2001;5:3-10)。